Todd B. Sisitsky is a partner of TPG, the global alternative asset management firm. He is the managing partner of TPG Capital, co-head of the firm's global health care investing platform and a member of the firm's Executive Committee. He has played leadership roles in connection with TPG's investments in:
- Adare Pharma (drug delivery and technology company)
- Aptalis Pharma (GI-focused specialty pharmaceutical company)
- Biomet (leading orthopedic implant manufacturer)
- Fenwal Transfusion Therapies (blood product technologies business)
- IASIS Healthcare (Tennessee-based acute care hospital company)
- Surgical Care Affiliates (ambulatory surgery center business carved out from HealthSouth Corporation)
- HealthScope (hospital and pathology company based in Australia)
- IMS Health (leading global data services and consulting business to several segments of the healthcare industry)
- Immucor (leading automated blood screening and testing business)
- Par Pharmaceutical (leading manufacturer and distributor of generic pharmaceutical products)
Sisitsky also serves on the board of directors of the global not-for-profit organization, the Campaign for Tobacco Free Kids, as well as on the Dartmouth Medical School Board of Overseers. Prior to joining TPG in 2003, Sisitsky worked at Forstmann Little & Company and Oak Hill Capital Partners. He received an M.B.A. from the Stanford Graduate School of Business, where he was an Arjay Miller Scholar, and earned his undergraduate degree from Dartmouth College, where he graduated summa cum laude.
